This page is reference information only. Most compounds described here are research chemicals, not FDA-approved medications. MyTRT does not sell, recommend, or endorse the use of these substances. Always consult a qualified physician.
Sema GLP-1
GLP-1 Receptor Agonist
/WHAT_IT_IS
Semaglutide is a GLP-1 receptor agonist that mimics the effects of glucagon-like peptide-1, helping regulate blood sugar and suppress appetite.
/USAGE
Commonly studied for weight loss, appetite control, and blood glucose regulation in individuals with metabolic conditions such as Type 2 diabetes and obesity.
/MECHANISM_OF_ACTION
Activates GLP-1 receptors to enhance insulin secretion, slow gastric emptying, suppress appetite, and reduce glucagon secretion.
Reported Benefits
- +Appetite suppression
- +Weight loss
- +Improved blood sugar control
- +Reduced risk of cardiovascular events
Reported Side Effects
- −Nausea
- −Constipation
- −Headache
- −Loss of appetite
/STACKED_WITH
/RESEARCH_NOTES
Semaglutide has become a leading GLP-1 analog in obesity and diabetes research, with strong clinical data supporting its effectiveness.
/REFERENCE
https://pubmed.ncbi.nlm.nih.gov/39476339//RELATED
Browse all 89 in the app.
MyTRT's in-app library has the same 89 peptide entries plus dosing notes, stack builders, and the ability to log them alongside your TRT protocol.